Life sciences · Journal article
Iraqi Journal of Science · October 30, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
Alzheimer's disease is a Declining neurological illness that mainly affects memory, thinking, and behaviour, leading to Significant deterioration in intellectual functioning of independence in daily routine. It impacts about 55 million people around the globe, with the number expected to rise significantly as the global population ages, making it one of the biggest public health challenges in current time. This study used a multi-case design to develop and test a deep learning model for classifying Alzheimer's disease stages from MRI scans. Two different datasets were used, the first one was used for the training and the other one was used for the validation task. Both of them used about 15000 images for the training and testing. A combination of VGG16 and LSTM neural networks was implemented using Keras and TensorFlow, with the VGG16 extracting visual features from MRI sequences which were then fed to an LSTM layer to classify sequences based on both visual and temporal dependencies. The model achieved 98.88% accuracy on the training set and 98.03% on the held-out validation set of 8,000 MRI images for classifying Alzheimer's disease stages. The combined VGG16-LSTM deep learning architecture demonstrated high performance in classifying Alzheimer's disease stages from MRI data, achieving over 98% accuracy. This research presents a promising automatic approach for diagnosis of Alzheimer's that has potential for clinical relevance